Matthew P. Morrow

5.2k total citations
68 papers, 2.5k citations indexed

About

Matthew P. Morrow is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Matthew P. Morrow has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 27 papers in Epidemiology and 15 papers in Molecular Biology. Recurrent topics in Matthew P. Morrow's work include Immunotherapy and Immune Responses (21 papers), HIV Research and Treatment (14 papers) and Cervical Cancer and HPV Research (14 papers). Matthew P. Morrow is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), HIV Research and Treatment (14 papers) and Cervical Cancer and HPV Research (14 papers). Matthew P. Morrow collaborates with scholars based in United States, Australia and Canada. Matthew P. Morrow's co-authors include David B. Weiner, Jian Yan, Niranjan Y. Sardesai, Bernadette Ferraro, Natalie A. Hutnick, Panyupa Pankhong, Amir Sada Khan, Jean Boyer, Zahedi Mujawar and Michael Bukrinsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nano Letters.

In The Last Decade

Matthew P. Morrow

65 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew P. Morrow United States 25 1.2k 655 562 417 387 68 2.5k
Vincent C. Bond United States 30 742 0.6× 516 0.8× 1.3k 2.3× 688 1.6× 415 1.1× 79 2.7k
Laura E. Ruff United States 15 1.7k 1.4× 635 1.0× 429 0.8× 1.5k 3.6× 604 1.6× 22 2.8k
Beda Břicháček United States 25 864 0.7× 653 1.0× 675 1.2× 1.5k 3.5× 882 2.3× 68 2.6k
Priscilla Biswas Italy 26 1.6k 1.3× 467 0.7× 303 0.5× 964 2.3× 487 1.3× 69 2.9k
Gary A. Jarvis United States 35 1.0k 0.8× 773 1.2× 834 1.5× 136 0.3× 407 1.1× 76 3.0k
Amir Horowitz United States 29 2.5k 2.1× 595 0.9× 492 0.9× 938 2.2× 571 1.5× 66 3.5k
Naglaa H. Shoukry Canada 33 1.9k 1.6× 2.2k 3.4× 473 0.8× 682 1.6× 449 1.2× 92 4.5k
Heribert Stoiber Austria 36 2.0k 1.6× 921 1.4× 570 1.0× 1.6k 3.8× 894 2.3× 119 3.6k
Christophe Vanpouille United States 29 710 0.6× 612 0.9× 1.1k 1.9× 836 2.0× 652 1.7× 71 2.5k
Fabrizio Manca Italy 25 1.3k 1.1× 560 0.9× 493 0.9× 557 1.3× 408 1.1× 117 2.3k

Countries citing papers authored by Matthew P. Morrow

Since Specialization
Citations

This map shows the geographic impact of Matthew P. Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew P. Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew P. Morrow more than expected).

Fields of papers citing papers by Matthew P. Morrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew P. Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew P. Morrow. The network helps show where Matthew P. Morrow may publish in the future.

Co-authorship network of co-authors of Matthew P. Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew P. Morrow. A scholar is included among the top collaborators of Matthew P. Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew P. Morrow. Matthew P. Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amin, Milan R., Peter C. Belafsky, Simon R. Best, et al.. (2025). DNA Immunotherapy ( INO ‐3107) Results in Long‐Term Surgery Reduction in RRP. The Laryngoscope. 135(11). 4287–4295. 1 indexed citations
2.
Morrow, Matthew P., et al.. (2023). Vaccines for HPV-associated diseases. Molecular Aspects of Medicine. 94. 101224–101224. 25 indexed citations
3.
Mau, Ted, Milan R. Amin, Peter C. Belafsky, et al.. (2023). Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis. The Laryngoscope. 133(11). 3087–3093. 21 indexed citations
4.
Jacobson, Jeffrey M., David M. Zahrieh, Carrie Strand, et al.. (2022). Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prevention Research. 16(3). 163–173. 11 indexed citations
5.
Hasan, Yasmin, Michael T. Spiotto, Larissa V. Furtado, et al.. (2018). A phase 1/2A trial of synthetic DNA vaccine immunotherapy targeting HPV-16 and -18 after chemoradiation for cervical cancer.. Journal of Clinical Oncology. 36(15_suppl). 5525–5525. 4 indexed citations
6.
Morrow, Matthew P., Kimberly A. Kraynyak, Albert J. Sylvester, et al.. (2017). Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy. Clinical Cancer Research. 24(2). 276–294. 34 indexed citations
7.
Villarreal, Daniel O., Megan C. Wise, Jewell Walters, et al.. (2014). Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity. Cancer Research. 74(6). 1789–1800. 111 indexed citations
8.
Morrow, Matthew P., Pablo Tebas, Jian Yan, et al.. (2014). Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals. Molecular Therapy. 23(3). 591–601. 14 indexed citations
9.
Morrow, Matthew P., Jian Yan, & Niranjan Y. Sardesai. (2013). Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer. Expert Review of Vaccines. 12(3). 271–283. 49 indexed citations
10.
Bagarazzi, Mark L., Jian Yan, Matthew P. Morrow, et al.. (2012). Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses. Science Translational Medicine. 4(155). 155ra138–155ra138. 229 indexed citations
11.
Ferraro, Bernadette, et al.. (2011). Clinical Applications of DNA Vaccines: Current Progress. Clinical Infectious Diseases. 53(3). 296–302. 275 indexed citations
12.
Fagone, Paolo, Devon J. Shedlock, Hongchu Bao, et al.. (2011). Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination. Gene Therapy. 18(11). 1070–1077. 47 indexed citations
13.
Broderick, Kate E., Xizhong Shen, Jonas Söderholm, et al.. (2010). Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Therapy. 18(3). 258–265. 50 indexed citations
14.
Morrow, Matthew P., Angela Grant, Zahedi Mujawar, et al.. (2010). Stimulation of the Liver X Receptor Pathway Inhibits HIV-1 Replication via Induction of ATP-Binding Cassette Transporter A1. Molecular Pharmacology. 78(2). 215–225. 50 indexed citations
15.
Morrow, Matthew P., et al.. (2009). Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood. 113(23). 5868–5877. 128 indexed citations
16.
Morrow, Matthew P., Devon J. Shedlock, Kenneth G. Schoenly, et al.. (2009). HIV-1 Vpr: Regulator of Viral Survival. Current HIV Research. 7(2). 153–162. 4 indexed citations
17.
Yan, Jian, David A. Hokey, Matthew P. Morrow, et al.. (2009). Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques. Vaccine. 27(25-26). 3260–3266. 15 indexed citations
18.
Morrow, Matthew P., Antonio Valentin, Richard F. Little, Robert Yarchoan, & George N. Pavlakis. (2008). A Splenic Marginal Zone-Like Peripheral Blood CD27 + B220 − B Cell Population Is Preferentially Depleted in HIV Type 1-Infected Individuals. AIDS Research and Human Retroviruses. 24(4). 621–633. 22 indexed citations
19.
Alicea, Candido, Antonio Valentin, Matthew P. Morrow, et al.. (2006). Long Lasting Control and Lack of Pathogenicity of the Attenuated Rev-Independent SIV in Rhesus Macaques. AIDS Research and Human Retroviruses. 22(6). 516–528. 8 indexed citations
20.
Mujawar, Zahedi, H Rose, Matthew P. Morrow, et al.. (2006). Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages. PLoS Biology. 4(11). e365–e365. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent C. Bond Breakdown of academic impact, for papers by Laura E. Ruff Breakdown of academic impact, for papers by Beda Břicháček Breakdown of academic impact, for papers by Priscilla Biswas Breakdown of academic impact, for papers by Gary A. Jarvis Breakdown of academic impact, for papers by Amir Horowitz Breakdown of academic impact, for papers by Naglaa H. Shoukry Breakdown of academic impact, for papers by Heribert Stoiber Breakdown of academic impact, for papers by Christophe Vanpouille Breakdown of academic impact, for papers by Fabrizio Manca
Rankless by CCL
2026